‘Torque control’- does it matter? Check out this🧵 to learn more! #Sponsored @AIU_Medical #ACCFIT #ACCEarlyCareer #ACCIC #ACCWIC @SCAI @scaiwin @poojaotherwise @Babar_Basir @yaqoub_lina @Hragy @HeartOTXHeartMD @willsuh76 @timir_paul @dcscant @dr_sabs_ @DrSaritaRao2 @sabeedak1

Hi everyone. Lots of fun stuff coming up next 6 months to raise visibility and pride in our field, workforce and societal impact! Grab a hat and get ready! @SCAI @Allison_Dupont @mirvatalasnag @djc795 @agtruesdell @Babar_Basir @CMichaelGibson @DLBHATTMD @pkothapalliMD

#Endovascular management of #RAthrombus - #TCT2025 https://t.co/qUBfrlTXSF @Cardio_Vumedi @SripalBangalore @timir_paul @agtruesdell @baileyannRN @DrJayMohan @MarwanSaadMD @stefan_harb @piccoloraf @sahilparikhmd @gbiondizoccai @DeepBlueDoc21 @jaygirimd @EricSecemskyMD @w_jyg

Check out our TIP on Coronary Microvascular Disease: Diagnosis and Management | SCAI ⁦@SCAI⁩ Concise tables on diagnosis and Rx. ⁦@UTHSCMedicine⁩ ⁦@uthscknoxville⁩ ⁦@OchsnerCardio⁩ ⁦@UNC⁩ ⁦@etsu⁩ ⁦@ACCinTouch⁩

Advanced Analyses of #CCT Angiography to Predict Future Cardiac Events: #MA

In 2 independent primary prevention cohorts, Lp(a) and IL-6 were independent predictors of #ASCVD risk, and their combination identified individuals at the highest risk. https://t.co/THvcjm9SJu #JACC #cvLipids

Lp(a) US family database. Open access

Among patients with high-grade stenosis without recent symptoms, the addition of stenting led to a lower risk of a composite of perioperative stroke or death or ipsilateral stroke within 4 years than intensive medical management alone. Carotid endarterectomy did not lead to a

See how policies in the 2026 #Medicare Physician Fee Schedule will impact your practice in the year ahead. Download #ACCAdvocacy's final rule calculator ➡️ https://t.co/1Jc8SINAVu

Editorial: Microaxial flow pump therapy may be most beneficial for myocardial infarction patients with cardiogenic shock experiencing severe hypotension despite vasopressor use. https://t.co/H5Z4vrFqMP

This post hoc analysis of the DanGer Shock RCT suggests that microaxial flow pump treatment may improve survival in patients with STEMI-related cardiogenic shock and profound systolic hypotension. https://t.co/Sq3pKzGrgq

Lipoprotein(a) and long-term structural valve degeneration of aortic bioprostheses #AVS

New #EJHF expert consensus on SMR in HF: 📌 Optimize GDMT + CRT first ✔️ then select pts for TEER/transcatheter options. New RCTs📊 may shift indications https://t.co/rFx54vTfIe @EJHFEiC @AmrAbdin10 @GiuseppeGalati_ @HanCardiomd

#CardioSmart will help you cheer on your patients with tools and resources on the benefits of quitting smoking, the effects smoking has on the heart, tips to quit and more. Learn more ➡️ https://t.co/ZjrtVQQIHC #GreatAmericanSmokeout

📢 Earn your FACC & CCK by passing the #CCKE! Prove your expertise, enhance your credentials, & take the next 👣 in your career! 🌍 The exam is open to licensed physicians outside the U.S. 🗓️ Learn more & apply by Nov. 26 to take the exam in December ➡️ https://t.co/LNN42pg60m

I gave what I heard yesterday a 24-hour cooling-off period. BUT… As a United States Army veteran, I find it inexcusable—and downright seditious—for elected officials to call on current service members to defy what they label “unlawful” orders when those orders are, in fact,

Variation in mechanical circulatory support use for acute myocardial infarction cardiogenic shock https://t.co/UnBX90yFCE

When's the right time to talk with aortic stenosis (AS) patients about treatment options and goals? Patients are ready earlier than HCPs expect. I’m collaborating with @EdwardsLifeSci on ways the Informed Decision Guide can help you start the conversation.

Check out tonite’s #ACCIC program on takeaways from #TCT2025 trials! #LBCT @ACCinTouch @SCAI @anna_bortnick @SVRaoMD @taraloujones #AkritiGupta #AjayKirtane! @SCAI @scaiwin @crfheart @SarasVallabhMD @SABOURETCardio @hvanspall @SrihariNaiduMD @dcscant @atunuguntla1 @timir_paul

Platelet-derived extracellular vesicles generated after myocardial infracture induces hematopoietic stem and progenitor cells proliferation - highlight potential new therapeutic targets @ParthaDuttaLab @Krispy_ed @ParthaDuttaLab https://t.co/d1tgTZeKm9